A common, over-the-counter supplement long favored by aging populations to combat joint discomfort and osteoarthritis may pose an unforeseen risk…
Read More
Targeting the Protein of Time: Stanford Researchers Restore Knee Cartilage and Prevent Arthritis in Mice, Offering Hope for Human Joint Regeneration
A groundbreaking medical study led by researchers at Stanford Medicine has demonstrated that targeting a specific protein linked to the…
Read More
The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties
The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…
Read More
University of Florida Study Suggests Popular Joint Supplement Glucosamine May Accelerate Cognitive Decline in Alzheimer’s Patients
A groundbreaking study led by researchers at the University of Florida has uncovered a potential link between the use of…
Read More
Common Joint Supplement Glucosamine Linked to Accelerated Alzheimer’s Progression in New University of Florida Research
New scientific evidence from the University of Florida suggests that glucosamine, a widely consumed over-the-counter supplement primarily marketed for joint…
Read More
Arna Pharma and Slate Run Pharmaceuticals Forge Strategic Joint Venture to Accelerate Pharmaceutical Product Commercialization in the US Market
Arna Pharma and Slate Run Pharmaceuticals have finalized a significant joint venture (JV), establishing a new specialized pharmaceutical entity poised…
Read More
The Joint Clinical Assessment: Navigating Procedural and Methodological Hurdles in EU Drug Evaluation
The advent of the Joint Clinical Assessment (JCA) process in the European Union, designed to harmonize the clinical evaluation of…
Read MoreYOU MAY HAVE MISSED
